Jim Simons An2 Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 579,773 shares of ANTX stock, worth $788,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
579,773
Previous 423,800
36.8%
Holding current value
$788,491
Previous $453,000
73.95%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.8MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5.75MShares$7.82 Million4.93% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.79 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.41 Million0.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$787,2020.79% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny528KShares$718,4880.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $26.4M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...